Low stroke rate and few thrombo-embolic events after HeartMate II implantation under mild anticoagulation.


OBJECTIVES Bleeding and thrombo-embolism are two of the most threatening adverse events associated with the use of continuous flow left ventricular assist devices (LVADs) in the treatment of severe heart failure. We analysed our LVAD patients treated with the HeartMate II (HM II) device by following a low anticoagulation regimen. METHODS Between 2008 and… (More)
DOI: 10.1093/ejcts/ezr312


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics